Somatuline
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Somatuline, covering 2024-06-14 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors [Phase 1, Phase 2]